Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?
Open Access
- 2 August 2016
- journal article
- health in-action
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 13 (8) , e1002062
Abstract
Kwonjune Seung and colleagues describe the Eugene Bell Foundation's experience of treating MDR-TB in North Korea.Keywords
This publication has 8 references indexed in Scilit:
- The Growing Problem of Multidrug-Resistant Tuberculosis in North KoreaPLOS Medicine, 2013
- Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis [Review article]The International Journal of Tuberculosis and Lung Disease, 2013
- Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 PatientsPLOS Medicine, 2012
- Treatment Outcome and Mortality among Patients with Multidrug-resistant Tuberculosis in Tuberculosis Hospitals of the Public SectorJournal of Korean Medical Science, 2011
- Treatment Outcomes and Survival Based on Drug Resistance Patterns in Multidrug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Cetyl-Pyridinium Chloride Is Useful for Isolation of Mycobacterium tuberculosis from Sputa Subjected to Long-Term StorageJournal of Clinical Microbiology, 2005
- Programmes and principles in treatment of multidrug-resistant tuberculosisThe Lancet, 2004
- Managerial successes, clinical failures.1999